EIF2AK3 and glioma: While many cell lines insensitive to dabrafenib demonstrate transiently decreased ERK phosphorylation in the presence of dabrafenib,45 dabrafenib-resistant glioma lines demonstrated reduced inhibition of pERK at 1 hour, suggesting an adaptive means of maintaining ERK activity.